This trial is to assess the function and safety of a device, with secondary objectives including feasibility.
2 Primary · 0 Secondary · Reporting Duration: 5 years
Experimental Treatment
6 Total Participants · 1 Treatment Group
Primary Treatment: responsive neurostimulation · No Placebo Group · N/A
Age 22 - 65 · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: